BioSpace News Archive

Sharps Technology, Inc. (the “Company”, “Sharps”) (NASDAQ: “STSS” and “STSSW”), an innovative medical device and drug delivery Company offering patented, best-in-class syringe products, is pleased to announce the signing of a distribution agreement with partner Nephron Pharmaceuticals.

Erasca, Inc. today announced the United States Food and Drug Administration (FDA) has cleared an investigational new drug (IND) application for ERAS-3490.

Renibus Therapeutics, Inc. today announced the appointment of Asha Ramdas as SVP, Program Management, Technical Operations and Manufacturing.

Envisagenics , an Artificial Intelligence (“AI”)-driven biotechnology company that delivers therapies for RNA splicing diseases, today announced a research collaboration agreement with Cancer Research Horizons, Cancer Research UK’s innovation engine, and Queen Mary University of London.

CoImmune, Inc. today announced the presentation of results from a Phase I/II clinical trial evaluating CARCIK-CD19.

vTv Therapeutics Inc. today announced the appointment of Steven Tuch as Chief Financial Officer, effective immediately.

Tellus Therapeutics announced today the closing of a Series A financing round of $35 million led by the Perceptive Xontogeny Venture Fund.

MAIA Biotechnology, Inc. (NYSE American: MAIA ) (“MAIA,” “the Company”), announced today that regulatory authorities in three European countries, Hungary, Poland, and Bulgaria, have approved the implementation of THIO-101, MAIA’s Phase 2 clinical trial evaluating its lead therapeutic candidate, THIO, in patients with Non-Small Cell Lung Cancer.

Quoin Pharmaceuticals Ltd. announces that the first patient has been dosed in its ongoing clinical trial evaluating the safety and efficacy of QRX003 as a treatment for Netherton Syndrome.

Novanta Inc. (Nasdaq: NOVT) (the “Company”) announced today that Robert Buckley, Chief Financial Officer, and Chuck Ravetto, Group President, are scheduled to present at the CJS Securities 23rd Annual New Ideas for the New Year Investor Conference on Wednesday, January 11, 2023, which is being held virtually.